Workout
Healthy Eating Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process Contact Us
Health Tracker
AI Tools
✔Fact Checked

The former Barcelona player takes the first step towards acquiring Espanyol

Article Updated On:
Photo of author
FitToFar
Published On:

Former Espanyol and Barcelona striker Martin Braithwaite has been rumored on several occasions to be interested in buying Los Pericos, but he has taken a first step towards a possible move. The Danish forward currently works for Gremio in Brazil.

However, Braithwaite returned to the stands when Espanyol drew with Valencia on Wednesday night, and that has once again reignited rumors that he would be interested in buying the club. La Grada (via Sport) says Braithwaite has retained the services of a major legal firm in Spain to potentially oversee the negotiation. They are currently evaluating the investment on your behalf. He would be looking for an investment partner to close the deal with him.

Various reports estimate Braithwaite’s net worth at around €300 million, having built a property empire during his football career. The 33-year-old also has a home in Barcelona since playing for the two Catalan giants, and left Los Pericos last summer after 3-5 years in the city. Espanyol is facing serious financial problems and Chinese president Chen Yansheng is reportedly considering a sale on behalf of the Rastar Group, which has sparked widespread protests against the owners in recent seasons.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

Read This Next


dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.

 

SHARE YOUR FEEDBACK

SHARE YOUR FEEDBACK